Automated interpretation of ANCA patterns - a new approach in the serology of ANCA-associated vasculitis

Arthritis Research and Therapy

Volumn 14, Issue 6, 2012, Pages

  Knütter, Ilka ^a   Hiemann, Rico ^b   Brumma, Therese ^a   Büttner, Thomas ^a   Großmann, Kai ^a   Cusini, Marco ^c   Pregnolato, Francesca ^d   Borghi, Maria O ^d   Anderer, Ursula ^b   Conrad, Karsten ^e   Reinhold, Dirk ^f   Roggenbuck, Dirk ^a,b   Csernok, Elena ^g  

^a GA GENERIC ASSAYS GMBH   (Germany)

^b Lausitz University of Applied Sciences   (Germany)

^c FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

^e DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^f OTTO VON GUERICKE UNIVERSITY   (Germany)

^g University of Schleswig Holstein Campus Lübeck and Rheumaklinik Bad Bramstedt ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADULT; AGED; ANCA ASSOCIATED VASCULITIS; ARTICLE; AUTOMATED PATTERN RECOGNITION; CONTROLLED STUDY; FEMALE; FLUORESCENCE MICROSCOPY; HUMAN; IMMUNOFLUORESCENCE; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL; READING; SEROLOGY; ALGORITHM; ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; BLOOD; COMPUTER PROGRAM; FLUORESCENT ANTIBODY TECHNIQUE; INFORMATION PROCESSING; MIDDLE AGED; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; AUTOMATIC DATA PROCESSING; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; MALE; MICROSCOPY, FLUORESCENCE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SOFTWARE; YOUNG ADULT;

EID: 84870940728     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar4119     Document Type: Article

References (34)

1. Bosch X, Guilabert A, Font J. Antineutrophil cytoplasmic antibodies. Lancet 2006, 368:404-18. 10.1016/S0140-6736(06)69114-9, 16876669.
2. Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, Hagen EC, Hoffman GS, Hunder GG, Kallenberg CG. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994, 37:187-92. 10.1002/art.1780370206, 8129773.
3. Falk RJ, Gross WL, Guillevin L, Hoffman GS, Jayne DR, Jennette JC, Kallenberg CG, Luqmani R, Mahr AD, Matteson EL, Merkel PA, Specks U, Watts RA. Granulomatosis with polyangiitis (Wegener's). an alternative name for Wegener's granulomatosis. Arthritis Rheum 2011, 63:863-4. 10.1002/art.30286, 21374588.
4. Savige JF, Gillis DF, Benson E, Davies DF, Esnault VF, Falk RJ, Hagen EC, Jayne D, Jennette JC, Paspaliaris B, Pollock W, Pusey C, Savage CO, Silvestrini R, van der Woude F, Wieslander J, Wiik A. International Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies (ANCA). Am J Clin Pathol 1999, 111:507-13.
5. Wiik A. Autoantibodies in vasculitis. Arthritis Res Ther 2003, 5:147-52. 165052, 12723981.
6. van der Woude FJ, Rasmussen N, Lobatto S, Wiik A, Permin H, van Es LA, van der Giessen M, van der Hem GK, The TH. Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet 1985, 1:425-9.
7. Conrad K, Schmechta H, Klafki A, Lobeck G, Uhlig HH, Gerdi S, Henker J. Serological differentiation of inflammatory bowel diseases. Eur J Gastroenterol Hepatol 2002, 14:129-35. 10.1097/00042737-200202000-00006, 11981336.
8. Joossens S, Daperno M, Shums Z, Van SK, Goeken JA, Trapani C, Norman GL, Godefridis G, Claessens G, Pera A, Pierik M, Vermeire S, Rutgeerts P, Bossuyt X. Interassay and interobserver variability in the detection of anti-neutrophil cytoplasmic antibodies in patients with ulcerative colitis. Clin Chem 2004, 50:1422-5. 10.1373/clinchem.2004.032318, 15277351.
9. Terjung B, Worman HJ, Herzog V, Sauerbruch T, Spengler U. Differentiation of antineutrophil nuclear antibodies in inflammatory bowel and autoimmune liver diseases from antineutrophil cytoplasmic antibodies (p-ANCA) using immunofluorescence microscopy. Clin Exp Immunol 2001, 126:37-46. 10.1046/j.1365-2249.2001.01649.x, 1906166, 11678897.
10. Craig WY, Ledue TB, Collins MF, Meggison WE, Leavitt LF, Ritchie RF. Serologic associations of anti-cytoplasmic antibodies identified during anti-nuclear antibody testing. Clin Chem Lab Med 2006, 44:1283-6.
11. McLaren JS, Stimson RH, McRorie ER, Coia JE, Luqmani RA. The diagnostic value of anti-neutrophil cytoplasmic antibody testing in a routine clinical setting. QJM 2001, 94:615-21. 10.1093/qjmed/94.11.615, 11704691.
12. Hiemann R, Buttner T, Krieger T, Roggenbuck D, Sack U, Conrad K. Challenges of automated screening and differentiation of non-organ specific autoantibodies on HEp-2 cells. Autoimmun Rev 2009, 9:17-22. 10.1016/j.autrev.2009.02.033, 19245860.
13. Egerer K, Roggenbuck D, Hiemann R, Weyer MG, Buttner T, Radau B, Krause R, Lehmann B, Feist E, Burmester GR. Automated evaluation of autoantibodies on human epithelial-2 cells as an approach to standardize cell-based immunofluorescence tests. Arthritis Res Ther 2010, 12:R40. 10.1186/ar2949, 2888187, 20214808.
14. Kivity S, Gilburd B, Agmon-Levin N, Carrasco MG, Tzafrir Y, Sofer Y, Mandel M, Buttner T, Roggenbuck D, Matucci-Cerinic M, Danko K, Hoyos ML, Shoenfeld Y. A novel automated indirect immunofluorescence autoantibody evaluation. Clin Rheumatol 2011, 31:503-9.
15. Roggenbuck D, Reinhold D, Hiemann R, Anderer U, Conrad K. Standardized detection of anti-ds DNA antibodies by indirect immunofluorescence - a new age for confirmatory tests in SLE diagnostics. Clin Chim Acta 2011, 412:2011-2. 10.1016/j.cca.2011.07.005, 21782805.
16. Melegari A, Bonaguri C, Russo A, Luisita B, Trenti T, Lippi G. A comparative study on the reliability of an automated system for the evaluation of cell-based indirect immunofluorescence. Autoimmun Rev 2012, 11:713-16. 10.1016/j.autrev.2011.12.010, 22269861.
17. Boomsma MM, Damoiseaux JG, Stegeman CA, Kallenberg CG, Patnaik M, Peter JB, Tervaert JW. Image analysis: a novel approach for the quantification of antineutrophil cytoplasmic antibody levels in patients with Wegener's granulomatosis. J Immunol Methods 2003, 274:27-35. 10.1016/S0022-1759(02)00273-9, 12609530.
18. Leavitt RY, Fauci AS, Bloch DA, Michel BA, Hunder GG, Arend WP, Calabrese LH, Fries JF, Lie JT, Lightfoot RW. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 1990, 33:1101-7.
19. deGroot K, Gross WL, Herlyn K, Reinhold-Keller E. Development and validation of a disease extent index for Wegener's granulomatosis. Clin Nephrol 2001, 55:31-8.
20. Luqmani RA, Bacon PA, Moots RJ, Janssen BA, Pall A, Emery P, Savage C, Adu D. Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. QJM 1994, 87:671-8.
21. Hiemann R, Hilger N, Sack U, Weigert M. Objective quality evaluation of fluorescence images to optimize automatic image acquisition. Cytometry A 2006, 69:182-4.
22. Bosch X, Font J, Mirapeix E, Revert L, Urbano-Marquez A, Ingelmo M. Anti-neutrophil cytoplasmic autoantibodies (ANCA): antigenic specificities and clinical associations. Adv Exp Med Biol 1993, 336:281-6.
23. Savige J, Gillis D, Benson E, Davies D, Esnault V, Falk RJ, Hagen EC, Jayne D, Jennette JC, Paspaliaris B, Pollock W, Pusey C, Savage CO, Silvestrini R, van der Woude F, Wieslander J, Wiik A. International Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies (ANCA). Am J Clin Pathol 1999, 111:507-13.
24. Tsiveriotis K, Tsirogianni A, Pipi E, Soufleros K, Papasteriades C. Antineutrophil cytoplasmic antibodies testing in a large cohort of unselected greek patients. Autoimmune Dis 2011, 2011:626495. 3112505, 21687647.
25. Csernok E, Holle JU. Twenty-eight years with antineutrophil cytoplasmic antibodies (ANCA): how to test for ANCA - evidence-based immunology?. Springer-Verlag 2010, 1:39-43.
26. Roggenbuck D, Buettner T, Hoffmann L, Schmechta H, Reinhold D, Conrad K. High-sensitivity detection of autoantibodies against proteinase-3 by a novel third-generation enzyme-linked immunosorbent assay. Ann N Y Acad Sci 2009, 1173:41-6. 10.1111/j.1749-6632.2009.04649.x, 19758130.
27. Hagen EC, Andrassy K, Csernok E, Daha MR, Gaskin G, Gross WL, Hansen B, Heigl Z, Hermans J, Jayne D, Kallenberg CG, Lesavre P, Lockwood CM, Lüdemann J, Mascart-Lemone F, Mirapeix E, Pusey CD, Rasmussen N, Sinico RA, Tzioufas A, Wieslander J, Wiik A, Van der Woude FJ. Development and standardization of solid phase assays for the detection of anti-neutrophil cytoplasmic antibodies (ANCA). A report on the second phase of an international cooperative study on the standardization of ANCA assays. J Immunol Methods 1996, 196:1-15. 10.1016/0022-1759(96)00111-1, 8841439.
28. Csernok E, Holle J, Hellmich B, Willem J, Tervaert C, Kallenberg CG, Limburg PC, Niles J, Pan G, Specks U, Westman K, Wieslander J, De Groot K, Gross WL. Evaluation of capture ELISA for detection of antineutrophil cytoplasmic antibodies directed against proteinase 3 in Wegener's granulomatosis: first results from a multicentre study. Rheumatology (Oxford) 2004, 43:174-80.
29. Csernok E, Ahlquist D, Ullrich S, Gross WL. A critical evaluation of commercial immunoassays for antineutrophil cytoplasmic antibodies directed against proteinase 3 and myeloperoxidase in Wegener's granulomatosis and microscopic polyangiitis. Rheumatology (Oxford) 2002, 41:1313-7.
30. Meroni PL, Schur PH. ANA screening: an old test with new recommendations. Ann Rheum Dis 2010, 69:1420-2. 10.1136/ard.2009.127100, 20511607.
31. Zöphel K, Wunderlich G, Kotzerke J, von Landenberg P, Roggenbuck D. M22 based (manual) ELISA for TSH-receptor antibody (TRAb) measurement is more sensitive than 2nd generation TRAb assays. Clin Chim Acta 2009, 403:266. 10.1016/j.cca.2009.01.022, 19361467.
32. Willitzki A, Hiemann R, Peters V, Sack U, Schierack P, Rödiger S, Anderer U, Conrad K, Bogdanos DP, Reinhold D, Roggenbuck D. New platform technology for comprehensive serological diagnostics of autoimmune diseases. Clin Dev Immunol 2012, 2012:284740.
33. Smith RM, Jones RB, Jayne DR. Progress in treatment of ANCA-associated vasculitis. Arthritis Res Ther 2012, 14:210. 10.1186/ar3797, 3446448, 22569190.
34. Vermeersch P, Blockmans D, Bossuyt X. Use of likelihood ratios can improve the clinical usefulness of enzyme immunoassays for the diagnosis of small-vessel vasculitis. Clin Chem 2009, 55:1886-8. 10.1373/clinchem.2009.130583, 19643836.